{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:47:19Z","timestamp":1786718839257,"version":"build-2736575974"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Can Res Ther"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/jcrt.jcrt_348_18","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T22:42:14Z","timestamp":1544136134000},"page":"1193","source":"Crossref","is-referenced-by-count":11,"title":["Combinatorial effect of curcumin and tumor necrosis factor-\u03b1-related apoptosis-inducing ligand (TRAIL) in induction of apoptosis via inhibition of nuclear factor kappa activity and enhancement of caspase-3 activity in chronic myeloid cells: An In-vitro study"],"prefix":"10.4103","volume":"14","author":[{"given":"Archna","family":"Ghildiyal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shraddha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahabjada","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratibha","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Arshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AA","family":"Mahdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0973-1482.245021-1","unstructured":"Lichtman MA. Chronic myelogenous leukemia and related disorders. In: Williams Hematology. 5th ed. New York: McGraw-Hill, Inc.; 1995. p. 298-324."},{"key":"key-10.4103\/0973-1482.245021-2","first-page":"1619","volume-title":"Curcumin as a regulator of epigenetic events","author":"Teiten","year":"2013","journal-title":"Mol Nutr Food Res"},{"key":"key-10.4103\/0973-1482.245021-3","first-page":"645","volume-title":"Potential anticancer properties and mechanisms of action of curcumin","author":"Vallianou","year":"2015","journal-title":"Anticancer Res"},{"key":"key-10.4103\/0973-1482.245021-4","first-page":"117","volume-title":"Induction of apoptosis by curcumin and its implications for cancer therapy","author":"Karunagaran","year":"2005","journal-title":"Curr Cancer Drug Targets"},{"key":"key-10.4103\/0973-1482.245021-5","first-page":"513","volume-title":"Mitochondrial control of cell death","author":"Kroemer","year":"2000","journal-title":"Nat Med"},{"key":"key-10.4103\/0973-1482.245021-6","first-page":"897","volume-title":"Molecular mechanisms of caspase regulation during apoptosis","author":"Riedl","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key-10.4103\/0973-1482.245021-7","first-page":"624","volume-title":"Effect of curcumin on caspase 8 \u2013 And caspase 9 \u2013 Induced apoptosis of lymphoma Raji cell","author":"Wu","year":"2005","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"key-10.4103\/0973-1482.245021-8","first-page":"431","volume-title":"Curcumin induces cell cycle arrest and apoptosis of prostate cancer cells by regulating the expression of ikappaBalpha, c-jun and androgen receptor","author":"Guo","year":"2013","journal-title":"Pharmazie"},{"key":"key-10.4103\/0973-1482.245021-9","first-page":"e16958","volume-title":"RNA binding protein CUGBP2\/CELF2 mediates curcumin-induced mitotic catastrophe of pancreatic cancer cells","author":"Subramaniam","year":"2011","journal-title":"PLoS One"},{"key":"key-10.4103\/0973-1482.245021-10","first-page":"210","volume-title":"Curcumin p38-dependently enhances the anticancer activity of valproic acid in human leukemia cells","author":"Chen","year":"2010","journal-title":"Eur J Pharm Sci"},{"key":"key-10.4103\/0973-1482.245021-11","first-page":"193","volume-title":"Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types","author":"Zhang","year":"2000","journal-title":"FEBS Lett"},{"key":"key-10.4103\/0973-1482.245021-12","first-page":"255","volume-title":"Apoptosis control by death and decoy receptors","author":"Ashkenazi","year":"1999","journal-title":"Curr Opin Cell Biol"},{"key":"key-10.4103\/0973-1482.245021-13","first-page":"815","volume-title":"An antagonist decoy receptor and a death domain-containing receptor for TRAIL","author":"Pan","year":"1997","journal-title":"Science"},{"key":"key-10.4103\/0973-1482.245021-14","first-page":"8628","volume-title":"TRAIL and apoptosis induction by TNF-family death receptors","author":"Wang","year":"2003","journal-title":"Oncogene"},{"key":"key-10.4103\/0973-1482.245021-15","first-page":"405","volume-title":"Structure, regulation and function of NF-kappa B","author":"Siebenlist","year":"1994","journal-title":"Annu Rev Cell Biol"},{"key":"key-10.4103\/0973-1482.245021-16","first-page":"141","volume-title":"Function and activation of NF-kappa B in the immune system","author":"Baeuerle","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"key-10.4103\/0973-1482.245021-17","first-page":"311","volume-title":"NF-kappaB activation is required for cisplatin-induced apoptosis in head and neck squamous carcinoma cells","author":"Kim","year":"2006","journal-title":"FEBS Lett"},{"key":"key-10.4103\/0973-1482.245021-18","first-page":"6853","volume-title":"Activators and target genes of Rel\/NF-kappaB transcription factors","author":"Pahl","year":"1999","journal-title":"Oncogene"},{"key":"key-10.4103\/0973-1482.245021-19","first-page":"24995","volume-title":"Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]","author":"Singh","year":"1995","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0973-1482.245021-20","first-page":"165","volume-title":"Cell sensitivity assays: The MTT assay","author":"Plumb","year":"2004","journal-title":"Methods Mol Med"},{"key":"key-10.4103\/0973-1482.245021-21","first-page":"2943","volume-title":"Anethole blocks both early and late cellular responses transduced by tumor necrosis factor: Effect on NF-kappaB, AP-1, JNK, MAPKK and apoptosis","author":"Chainy","year":"2000","journal-title":"Oncogene"},{"key":"key-10.4103\/0973-1482.245021-22","unstructured":"Qadir MI, Naqvi ST, Muhammad SA. Curcumin: A Polyphenol with molecular targets for cancer control. Asian Pac J Cancer Prev 2016;17:2735-9."},{"key":"key-10.4103\/0973-1482.245021-23","first-page":"818","volume-title":"Curcumin and its analogues: Potential anticancer agents","author":"Agrawal","year":"2010","journal-title":"Med Res Rev"},{"key":"key-10.4103\/0973-1482.245021-24","first-page":"2351","volume-title":"Antioxidation and tyrosinase inhibition of polyphenolic curcumin analogs","author":"Du","year":"2011","journal-title":"Biosci Biotechnol Biochem"},{"key":"key-10.4103\/0973-1482.245021-25","first-page":"1","volume-title":"Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence","author":"Block","year":"1992","journal-title":"Nutr Cancer"},{"key":"key-10.4103\/0973-1482.245021-26","first-page":"541","volume-title":"The role of soy products in reducing risk of cancer","author":"Messina","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"key-10.4103\/0973-1482.245021-27","first-page":"287","volume-title":"Curcumin dietary supplements and everolimus-based cancer treatment","author":"Mir","year":"2018","journal-title":"Ann Oncol"},{"key":"key-10.4103\/0973-1482.245021-28","first-page":"1333","volume-title":"Nonselective inhibition of proliferation of transformed and nontransformed cells by the anticancer agent curcumin (diferuloylmethane)","author":"Gautam","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"key-10.4103\/0973-1482.245021-29","first-page":"181","volume-title":"The study of pentoxifylline drug effects on renal apoptosis and BCL-2 gene expression changes following ischemic reperfusion injury in rat","author":"Hashemi","year":"2014","journal-title":"Iran J Pharm Res"},{"key":"key-10.4103\/0973-1482.245021-30","first-page":"56","volume-title":"Curcumin in various cancers","author":"Shehzad","year":"2013","journal-title":"Biofactors"},{"key":"key-10.4103\/0973-1482.245021-31","first-page":"111","volume-title":"Inhibitory effect of curcuminoids on MCF-7 cell proliferation and structure-activity relationships","author":"Simon","year":"1998","journal-title":"Cancer Lett"},{"key":"key-10.4103\/0973-1482.245021-32","first-page":"257","volume-title":"Therapeutic efficacy of curcumin\/TRAIL combination regimen for hormone-refractory prostate cancer","author":"Andrzejewski","year":"2008","journal-title":"Oncol Res"},{"key":"key-10.4103\/0973-1482.245021-33","first-page":"803","volume-title":"Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand\/Apo2L by inhibiting nuclear factor-kappa B through suppression of ikappaBalpha phosphorylation","author":"Deeb","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"key-10.4103\/0973-1482.245021-34","first-page":"347","volume-title":"Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance","author":"Brenes","year":"2007","journal-title":"Biomed Pharmacother"},{"key":"key-10.4103\/0973-1482.245021-35","first-page":"1","volume-title":"Caspases: The executioners of apoptosis","author":"Cohen","year":"1997","journal-title":"Biochem J"},{"key":"key-10.4103\/0973-1482.245021-36","first-page":"42","volume-title":"Induction of apoptosis by cancer chemotherapy","author":"Kaufmann","year":"2000","journal-title":"Exp Cell Res"},{"key":"key-10.4103\/0973-1482.245021-37","first-page":"526","volume-title":"Programmed cell death: Alive and well in the new millennium","author":"Kaufmann","year":"2001","journal-title":"Trends Cell Biol"},{"key":"key-10.4103\/0973-1482.245021-38","first-page":"459","volume-title":"Mechanisms of caspase activation and inhibition during apoptosis","author":"Shi","year":"2002","journal-title":"Mol Cell"},{"key":"key-10.4103\/0973-1482.245021-39","first-page":"10","volume-title":"Curcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells: Molecular mechanisms of apoptosis, migration and angiogenesis","author":"Shankar","year":"2007","journal-title":"J Mol Signal"},{"key":"key-10.4103\/0973-1482.245021-40","first-page":"775","volume-title":"Inhibiting NF-\u03baB activation by small molecules as a therapeutic strategy","author":"Gupta","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"key-10.4103\/0973-1482.245021-41","first-page":"705","volume-title":"Multiple nuclear factors interact with the immunoglobulin enhancer sequences","author":"Sen","year":"1986","journal-title":"Cell"},{"key":"key-10.4103\/0973-1482.245021-42","first-page":"1857","volume-title":"Curcumin suppresses vasculogenic mimicry capacity of hepatocellular carcinoma cells through STAT3 and PI3K\/AKT inhibition","author":"Chiablaem","year":"2014","journal-title":"Anticancer Res"},{"key":"key-10.4103\/0973-1482.245021-43","first-page":"524161","volume-title":"Synthesis, characterization and in vitro anticancer activity of C-5 curcumin analogues with potential to inhibit TNF-\u03b1-induced NF-\u03baB activation","author":"Anthwal","year":"2014","journal-title":"Biomed Res Int"},{"key":"key-10.4103\/0973-1482.245021-44","first-page":"654","volume-title":"Inhibition of ikappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2-flurobenzylidene) piperidin-4-one (EF24), a novel monoketone analog of curcumin","author":"Kasinski","year":"2008","journal-title":"Mol Pharmacol"},{"key":"key-10.4103\/0973-1482.245021-45","first-page":"1053","volume-title":"Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and ikappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis","author":"Bharti","year":"2003","journal-title":"Blood"},{"key":"key-10.4103\/0973-1482.245021-46","first-page":"1242","volume-title":"Colon carcinogenesis: Influence of western diet-induced obesity and targeting stem cells using dietary bioactive compounds","author":"Kasdagly","year":"2014","journal-title":"Nutrition"},{"key":"key-10.4103\/0973-1482.245021-47","first-page":"1665","volume-title":"Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages","author":"Pan","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"key-10.4103\/0973-1482.245021-48","first-page":"14008","volume-title":"Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma huT-78 cells.Autocrine role of tumor necrosis factor and reactive oxygen intermediates","author":"Giri","year":"1998","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0973-1482.245021-49","first-page":"2844","volume-title":"Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells","author":"Estrov","year":"1999","journal-title":"Blood"},{"key":"key-10.4103\/0973-1482.245021-50","first-page":"63","volume-title":"Cancer.Addiction to oncogenes \u2013 The Achilles heal of cancer","author":"Weinstein","year":"2002","journal-title":"Science"},{"key":"key-10.4103\/0973-1482.245021-51","first-page":"24625","volume-title":"Inhibition of tumor necrosis factor-alpha \u2013 Induced nuclear translocation and activation of NF-kappa B by dehydroxymethylepoxyquinomicin","author":"Ariga","year":"2002","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0973-1482.245021-52","first-page":"561","volume-title":"IAPs: From caspase inhibitors to modulators of NF-kappaB, inflammation and cancer","author":"Gyrd-Hansen","year":"2010","journal-title":"Nat Rev Cancer"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:40:23Z","timestamp":1786714823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_348_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018]]}},"alternative-id":["245021"],"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_348_18","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}